Services
Research and Clinical Development
Regulatory
Clinical
Biometrics
CMC
Consulting
Management Consulting
Market Access
Patient Engagement
Transaction Advisory
Lifecycle Optimization
Lifecycle Optimization
Real-World Solutions
Real-World Solutions
Biotech
Biotech
Technology
Health Storylines
A digital platform that puts patients at the center and intersection of human networks, technology, and science
b.research
A single, unified SaaS solution for all EU Phase 4, Real-World Evidence, and Post-Approval studies
RedCrow
An equity crowdfunding and crowdsourcing platform for healthcare innovation
About
Our team
Our team collaborates to fully understand every aspect of each client’s organization from concept ideation to commercial realization, from innovation to implementation
Community involvement
We work with our local and global communities to create positive change through education, service, and sustainable business practices
800+
employees
90+%
has a PhD and/or Masters
15
languages spoken
30
nationalities
Careers
Job openings
Explore our job openings and find the one that is right for you
Why work at Alira Health?
Alira Health is dedicated to providing market-leading professional development, education, travel, and work-life benefits to all team members
Join our team
Join our global team dedicated to innovation and initiative, where physical walls and different time zones don’t limit, but encourage, collaboration
Resources
News
Read all the latest from us
Blog
Insights on healthcare innovation and more
Events
Check out our upcoming events
Publications
Discover our latest industry infographics, articles, white papers, and more
Multimedia
Visit our videos, podcasts, webinars, and more.
Latest in the hub
Manufacturing Challenges of Therapeutic Antibody-Drug Conjugates
Published: September, 2023
UK HTA Approves TRANSLARNA (Ataluren) for Duchenne Muscular Dystrophy Citing Real-World Evidence
Published: September, 2023
Opportunities and Challenges in the Therapeutic and CDMO Markets
Published: September, 2023
Services
Overview
Research and Clinical Development
Regulatory Clinical Biometrics CMC
Consulting
Management Consulting Market Access Patient Engagement Transaction Advisory Lifecycle Optimization
Real-World Solutions
Real-World Solutions
Biotech
Biotech
Technology
Overview Health Storylines b.research RedCrow
About
Overview Our team Community involvement
Careers
Overview Job openings Why work at Alira Health? Join our team
Resources
Overview News Blog Events Publications Multimedia
Home > Education Hub > SCOPE Europe 2022

SCOPE Europe 2022

April 20-21, 2022 | Barcelona, Spain

We are thrilled to announce that this year we will be joining the 4th Annual Summit for Clinical Trials Operations Executives Europe (SCOPE Europe). SCOPE Europe is a two-day hybrid event serving clinical innovation leaders, clin ops execs, digital leaders, functional heads, category managers, and those responsible for the planning and management of clinical trials in Europe and the Rest of the World. 

This year, we will attend as delegate and speakers. Alessandro Monterosso, Director, Digital Health Solutions of Alira Health, will be joining a panel discussion “Reimagining Clinical Trials: The Digital Transformation in Catalonia” moderated by Montse Daban, Director, Scientific and International Relations of Biocat.  

Events
Category:
Clinical
Published on:
April 12, 2022
Our panelist:
Alessandro Monterosso

Alessandro Monterosso

 Director, Digital Health Solutions, Alira Health Alessandro started his professional career as a Clinical Research Nurse, conducting studies first in Pediatrics and after graduating in applied Research, in Oncology. He co-authored several research papers and a handbook on clinical nursing procedures. In 2018, Alessandro worked at Ferring pharmaceuticals, leading Patient centricity programs in women’s health. In 2018, he graduated from SDA Bocconi in International Healthcare Management, Economics, and Policy, and in 2020, he graduated in Leadership and Innovation at the Massachusetts Institute of Technology.
Our delegate:
Camille Vinçon

Camille Vinçon

 Business Development Director
Book your meeting with us at SCOPE Europe

Related news

Publications July 11, 2023
Five Years Evolution of Chemotherapy Administration in Home Care in France
Have a look at the poster to get an overview of the dynamics in the development of chemotherapy in home care across different French regions during a five-year period.
Clinical France Outcomes Research
Events June 20, 2023
Advanced Wound Care Summit
We are pleased to announce that we will sponsor, attend, and speak at Advanced Wound Care Summit.
Clinical Clinical Trials Wound Healing
Events February 2, 2023
ACDM 2023
We are pleased to announce that we will be sponsoring and attending ACDM 2023. ACDM23 offers a full two-day program of expert speakers, specialist panels, workshops and debates which(...)
Clinical Data Science
Blog December 21, 2022
2022 Recap: Your Favorite Alira Health Publications
In 2022, the Alira Health team of scientists, strategists, economists, clinicians, and biostatisticians shared actionable insights, industry thought leadership, and leading-edge guidance(...)
Clinical Digital Health Market Access MedTech Pharma Regulatory
Blog December 14, 2022
How to Optimize Clinical Research with Patient Advisory Boards
Patient engagement is increasingly essential to all stages of product development—particularly clinical research.
Clinical Patient Advocacy Patient Centricity
Events November 30, 2022
Innovations in Wound Healing
We are excited to attend and sponsor a poster presentation at the Innovations in Wound Healing event this year. This unique meeting is led by a group of experienced educators, scientists(...)
Clinical Patient Centricity Wound Healing
Publications September 16, 2022
Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials
The rise of technology in clinical research allows us to capture meaningful aspects of health in clinical study participants.
Biometrics Clinical eCOA
See all news
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.